Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Dec 29, 2016 at 10:30 AM EST

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

The Dow has been within 1% of 20,000 for days now. What if the Dow actually manages to hit 22,000…

Douglas A. McIntyre | Dec 29, 2016 at 7:35 AM EST

5 Companies That Will Kill the Dow’s Move to 20,000

Most of the 30 components of the Dow Jones Industrial Average have risen by double-digit percentages this year. But these…

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Douglas A. McIntyre | Dec 22, 2016 at 6:40 AM EST

5 Stocks That Will Keep the Dow Under 20,000

Dow 20,000 does not need all of the index's components to do well. However, these five could be a big…

Paul Ausick | Dec 21, 2016 at 4:01 PM EST

Merck, Pfizer Weigh on DJIA Wednesday

December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think…

Chris Lange | Dec 19, 2016 at 12:20 PM EST

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key…

Paul Ausick | Dec 12, 2016 at 4:01 PM EST

J&J, Wal-Mart Lift Dow Higher Monday

December 12, 2016: Markets opened mixed Monday as traders position themselves for the FOMC meeting announcement due on Wednesday. An…

Jon C. Ogg | Dec 12, 2016 at 11:10 AM EST

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

At the end of each year, investors look for opportunities and safe harbors to park their money for the year…

Chris Lange | Dec 12, 2016 at 8:44 AM EST

Short Sellers Back Way Off Major Pharma Stocks

The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected…

Paul Ausick | Dec 11, 2016 at 9:18 AM EST

Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow

With three weeks remaining in 2016, just four DJIA stocks are trading down for the year and all but one…

Paul Ausick | Dec 9, 2016 at 4:01 PM EST

Pfizer, Coca-Cola Lead Dow Higher Friday

December 9, 2016: Markets opened higher again Friday with little support from either economic data or corporate earnings. One big…

Jon C. Ogg | Dec 6, 2016 at 11:35 AM EST

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

It turns out that 11 of the 30 Dow Jones Industrial Average stocks have a consensus price target that calls…

Lee Jackson | Dec 1, 2016 at 8:10 AM EST

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for…

Paul Ausick | Nov 29, 2016 at 4:01 PM EST

Boeing, UnitedHealth Dominate DJIA Tuesday

November 29, 2016: Markets opened higher Tuesday following the Commerce Department’s second estimate of third quarter GDP growth of 3.2%.…

Chris Lange | Nov 28, 2016 at 7:15 AM EST

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the…

1 … 42 43 44 45 46 … 98

Pfizer : PFE

All Pfizer Articles

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Short Interest Rises in Major Pharma

5 Stocks That Will Keep the Dow Under 20,000

Merck, Pfizer Weigh on DJIA Wednesday

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

J&J, Wal-Mart Lift Dow Higher Monday

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

Short Sellers Back Way Off Major Pharma Stocks

Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow

Pfizer, Coca-Cola Lead Dow Higher Friday

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Boeing, UnitedHealth Dominate DJIA Tuesday

Short Sellers Hike Their Bets in Most Major Pharma Stocks

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Pfizer : PFE

All Pfizer Articles

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Short Interest Rises in Major Pharma

5 Stocks That Will Keep the Dow Under 20,000

Merck, Pfizer Weigh on DJIA Wednesday

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

J&J, Wal-Mart Lift Dow Higher Monday

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

Short Sellers Back Way Off Major Pharma Stocks

Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow

Pfizer, Coca-Cola Lead Dow Higher Friday

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Boeing, UnitedHealth Dominate DJIA Tuesday

Short Sellers Hike Their Bets in Most Major Pharma Stocks

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up